Antibody Effector Mechanisms in Myasthenia Gravis: The Complement Hypothesisa

This publication has 49 references indexed in Scilit:

• Expression and Initial Characterization of Recombinant Antiacetylcholine Receptor Antibodies in Experimental Autoimmune Myasthenia Gravis^a
  Annals of the New York Academy of Sciences, 1998
• The Pathogenic Role of Acetylcholine Receptor α Chain Epitope within α146-162 in the Development of Experimental Autoimmune Myasthenia Gravis in C57BL6 Mice
  Clinical Immunology and Immunopathology, 1994
• Myasthenia Gravis
  New England Journal of Medicine, 1994
• The Nicotinic Acetylcholine Receptor: Structure and Autoimmune Pathology
  Critical Reviews in Biochemistry and Molecular Biology, 1994
• Myasthenia gravis: recognition of a human autoantigen at the molecular level
  Immunology Today, 1993
• Effector Mechanisms of Myasthenic Antibodies
  Annals of the New York Academy of Sciences, 1993
• The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies
  Molecular Neurobiology, 1991
• Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia Gravis
  New England Journal of Medicine, 1982
• Monoclonal antibodies against defined determinants of acetylcholine receptor
  FEBS Letters, 1979
• Monoclonal antibodies against purified nicotinic acetylcholine receptor
  Biochemical and Biophysical Research Communications, 1979